Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain

被引:71
|
作者
Xie, C [1 ]
Zhou, XJ [1 ]
Liu, XB [1 ]
Mohan, C [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med Rheumatol, Simmons Arthrit Res Ctr, Dallas, TX 75390 USA
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 04期
关键词
D O I
10.1002/art.10887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Although the NZW mouse strain is phenotypically normal, fulminant lupus glomerulonephritis (GN) develops when NZW mice are bred to several other strains, such as NZB, BXSB, B6.Sle1, and B6.Yaa. Based on the observation that aging NZW mice exhibit histologic evidence of GN, we sought to test our hypothesis that NZW mice may be more susceptible to immune-mediated renal damage. Methods. NZW mice, as well as C57BL/6 (B6) and BALB/c control mice, were challenged with rabbit antiglomerular basement membrane nephrotoxic sera (NTS), to induce renal disease. The different mouse strains were monitored for the degree of clinical disease, renal pathology, chemokine profiles, and cellular infiltrates. Results. Although the NZW and control strains showed similar glomerular deposits of rabbit Ig and exhibited similar levels of anti-rabbit xenogeneic immune response, the NZW mice had significantly worse pathologic changes and disease. Compared with the control strains, the NTS-injected NZW mice demonstrated significantly increased proteinuria, elevated blood urea nitrogen levels, more severe histologic GN and tubulointerstitial nephritis, increased glomerular crescent formation with macrophage and neutrophil infiltrates, elevated expression of CC and CXC chemokines (monocyte chemoattractant protein 1, RANTES, KC), and significantly accelerated mortality. Importantly, these changes occurred within a few days after NTS administration. Finally, (B6 x NZW)F-1 mice were as susceptible as the NZW parents, which indicates dominant NZW contributions. Conclusion. Collectively, these findings support the notion that a lupus-facilitating genome may contribute to disease susceptibility by modulating the degree of immune-mediated end-organ damage. The availability of B6-based congenic strains bearing individual NZW-derived lupus susceptibility loci will permit future genetic dissection of end-organ susceptibility in murine lupus.
引用
收藏
页码:1080 / 1092
页数:13
相关论文
共 50 条
  • [1] End-organ susceptibility as a determinant of renal disease in hypertension
    Raij, L
    Madias, NE
    Lenz, O
    Epstein, M
    Jaimes, EA
    Materson, BJ
    Banerjee, D
    Preston, RA
    Roth, D
    Abraira, C
    KIDNEY INTERNATIONAL, 2003, 64 (05) : 1923 - 1932
  • [2] Pharmacogenomics and end-organ susceptibility to injury in the perioperative period
    Schwinn, Debra A.
    Podgoreanu, Mihai
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2008, 22 (01) : 23 - 37
  • [3] Lupus glomerulonephritis revisited 2004: Autoimmunity and end-organ damage
    Bagavant, H
    Deshmukh, US
    Gaskin, F
    Fu, SM
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (1-2) : 52 - 63
  • [4] Assessing the brain as an end-organ of vascular disease
    Charles DeCarli
    Nature Reviews Cardiology, 2012, 9 : 435 - 436
  • [5] Assessing the brain as an end-organ of vascular disease
    DeCarli, Charles
    NATURE REVIEWS CARDIOLOGY, 2012, 9 (08) : 435 - 436
  • [6] Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response
    Ochodnicky, Peter
    Vettoretti, Simone
    Henning, Robert H.
    Buikema, Hendrik
    van Dokkum, Richard P. E.
    de Zeeuw, Dick
    JOURNAL OF NEPHROLOGY, 2006, 19 (03) : 246 - 258
  • [7] ENHANCED END-ORGAN RESPONSIVENESS OF UREMIC KIDNEY TO NATRIURETIC FACTOR
    FINE, LG
    BOURGOIGNIE, JJ
    WEBER, H
    BRICKER, NS
    KIDNEY INTERNATIONAL, 1976, 10 (05) : 364 - 372
  • [8] Interleukin-18 receptor signaling is not required for autoantibody production and end-organ disease in murine lupus
    Lin, Ling
    Peng, Stanford L.
    ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 984 - 986
  • [9] Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways
    Pellerin, Alex
    Tan, Ying
    Lu, Simon
    Bonegio, Ramon G.
    Rifkin, Ian R.
    JOURNAL OF IMMUNOLOGY, 2023, 211 (09): : 1308 - 1319
  • [10] Skin cancer in organ transplant recipients Effect of pretransplant end-organ disease
    Otley, CC
    Cherikh, WS
    Salasche, SJ
    McBride, MA
    Christenson, LJ
    Kauffman, HM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (05) : 783 - 790